Results 261 to 270 of about 6,504,273 (325)

Woa-wtconv-kanformer for long term time series forecasting. [PDF]

PLoS One
Ling Ming M, Wei Min Q, Yi Fan D, Yu Ning Z.   +3 more
europepmc   +1 more source

Prediction of the Behavior for Polymer Blends Using Thermodynamic Model

, 2019
Chasib KF
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

A Natural Gas Energy Metering Method Based on Density-Sound Velocity Correlation. [PDF]

Sensors (Basel)
Zhang B, Huang Z, Wang W, Wang J, Xie D, Cheng Y, Yang Y.   +6 more
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Machine Learning Model for Sepsis Prediction in Prolonged and Chronic Critical Illness: Development and Validation Using Retrospective Real-World ICU Data. [PDF]

J Clin Med
Yadgarov MY, Rebrova OY, Berikashvili LB, Polyakov PA, Kadantseva KK, Yakovlev AA, Grechko AV, Likhvantsev VV.   +7 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

A data analytics-driven approach to backorder prediction using federated machine learning in industrial supply chains. [PDF]

Sci Rep
Sattar A, Bukhari M, Rehman ZU, Khalid S, Lee Y, Rho S.   +5 more
europepmc   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Uncertainty-aware machine learning to predict non-cancer human toxicity for the global chemicals market. [PDF]

Nat Commun
von Borries K, Beckwith KV, Goodman JM, Chiu WA, Jolliet O, Fantke P.   +5 more
europepmc   +1 more source